Progress of Nanomaterials Based on Manganese Dioxide in the Field of Tumor Diagnosis and Therapy.
Int J Nanomedicine
; 19: 8883-8900, 2024.
Article
en En
| MEDLINE
| ID: mdl-39224196
ABSTRACT
As a pivotal transition metal oxide, manganese dioxide (MnO2) has garnered significant attention owing to its abundant reserves, diverse crystal structures and exceptional performance. Nanosizing MnO2 results in smaller particle sizes, larger specific surface areas, optimized material characteristics, and expanded application possibilities. With the burgeoning research efforts in this field, MnO2 has emerged as a promising nanomaterial for tumor diagnosis and therapy. The distinctive properties of MnO2 in regulating the tumor microenvironment (TME) have attracted considerable interest, leading to a rapid growth in research on MnO2-based nanomaterials for tumor diagnosis and treatment. Additionally, MnO2 nanomaterials are also gradually showing up in the regulation of chronic inflammatory diseases. In this review, we mainly summarized the recent advancements in various MnO2 nanomaterials for tumor diagnosis and therapy. Furthermore, we discuss the current challenges and future directions in the development of MnO2 nanomaterials, while also envisaging their potential for clinical translation.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Óxidos
/
Compuestos de Manganeso
/
Nanoestructuras
/
Microambiente Tumoral
/
Neoplasias
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Int J Nanomedicine
/
Int. j. nanomed. (Online)
/
International journal of nanomedicine (Online)
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Nueva Zelanda